At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 156 enrolled
Drug / intervention
Bromfenac +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
In Brief
A Phase 3 clinical trial evaluating Bromfenac and Placebo for Cataract. Completed, enrolled 156 participants across 1 site.
Detailed Summary
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2008
First PostedJun 2008
Primary CompletionJan 2009
Study CompletionDec 2009
TodayJul 2026
First PostedJun 24, 2008
Enrollment StartJun 1, 2008
Primary CompletionJan 1, 2009
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 18.0 years ago
Interventions
Bromfenacdrug
sterile ophthalmic solution
Placebodrug
sterile ophthalmic solution